Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility

被引:40
作者
McCall, MR [1 ]
La Belle, M [1 ]
Forte, TM [1 ]
Krauss, RM [1 ]
Takanami, Y [1 ]
Tribble, DL [1 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Nucl Med,Donner Lab, Div Life Sci, Ernest Orlando Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 1999年 / 1437卷 / 01期
关键词
LDL subfraction; inflammation; lipoprotein oxidation;
D O I
10.1016/S0005-2760(98)00177-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor acetylhydrolase (PAF-AH) is transported by lipoproteins in plasma and is thought to possess both anti-inflammatory and anti-oxidative activity. It has been reported that PAF-AH is recovered primarily in small, dense LDL and HDL following ultracentrifugal separation of lipoproteins. In the present studies, we aimed to further define the distribution of PAF-AH among lipoprotein fractions and subfractions, and to determine whether these distributions are affected by the lipoprotein isolation strategy (FPLC versus sequential ultracentrifugation) and LDL particle distribution profile. When lipoproteins were isolated by FPLC, the bull; (similar to 85%) of plasma PAF-AH activity was recovered within LDL-containing fractions, whereas with ultracentrifugation, there was a redistribution to HDL (which contained similar to 18% of the activity) and the d > 1.21 g/ml fraction (which contained similar to 32%). Notably, re-ultracentrifugation of isolated LDL did not result in any further movement of PAF-AH to higher densities, suggesting the presence of dissociable and nondissociable forms of the enzyme on LDL. Differences were noted in the distribution of PAF-AH activity among LDL subfractions from subjects exhibiting the pattern A (primarily large, buoyant LDL) versus pattern B (primarily small, dense LDL) phenotype. In the latter group, there was a relative depletion of PAF-AH activity in subfractions in the intermediate to dense range (d= 1.039-1.047 g/ml) with a corresponding increase in enzyme activity recovered within the d> 1.21 g/ml ultracentrifugal fraction. Thus, there appears to be a greater proportion of the dissociable form of PAF-AH in pattern B subjects. In both populations, most of the nondissociable activity was recovered in a minor small, dense LDL subfraction. Based on conjugated dienes as a measure of lipid peroxidation, variations in PAF-AH activity appeared to contribute to variations in oxidative behavior among ultracentrifugally isolated LDL subfractions. The physiologic relevance of PAF-AH dissociability and the minor PAF-AH-enriched oxidation-resistant LDL subpopulation remains to be determined. Science B.V. All rights reserved.
引用
收藏
页码:23 / 36
页数:14
相关论文
共 37 条
[1]  
ASSMANN G, 1993, CIRCULATION, V87, P28
[2]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[3]  
BLANK ML, 1981, J BIOL CHEM, V256, P175
[4]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[5]   THE GENETIC-BASIS OF LIPOPROTEIN DISORDERS INTRODUCTION AND OVERVIEW [J].
BRESLOW, JL .
JOURNAL OF INTERNAL MEDICINE, 1992, 231 (06) :627-631
[6]   SUSCEPTIBILITY OF SMALL, DENSE, LOW-DENSITY LIPOPROTEINS TO OXIDATIVE MODIFICATION IN SUBJECTS WITH THE ATHEROGENIC LIPOPROTEIN PHENOTYPE, PATTERN-B [J].
CHAIT, A ;
BRAZG, RL ;
TRIBBLE, DL ;
KRAUSS, RM .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04) :350-356
[7]   ENHANCED SUSCEPTIBILITY TO INVITRO OXIDATION OF THE DENSE LOW-DENSITY-LIPOPROTEIN SUBFRACTION IN HEALTHY-SUBJECTS [J].
DEGRAAF, J ;
HAKLEMMERS, HLM ;
HECTORS, MPC ;
DEMACKER, PNM ;
HENDRIKS, JCM ;
STALENHOEF, AFH .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :298-306
[8]  
DEJAGER S, 1993, J LIPID RES, V34, P295
[9]   Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase [J].
Dentan, C ;
Tselepis, AD ;
Chapman, MJ ;
Ninio, E .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (03) :353-357
[10]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390